Immuno Cancer Biotherapeutics

Seed
icbiothera.com Biotech & Healthcare Canton, United States
Total Funding Undisclosed
Latest Round Undisclosed Seed
Last Announced Oct 15, 2026
Investors Undisclosed
Decision Makers Profile Active

About Immuno Cancer Biotherapeutics

Immuno Cancer Biotherapeutics is developing polyclonal antibody based therapies to target and overcome cancer heterogeneity and resistance.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Seed
Global Headquarters Canton, United States
Tracked Since Oct 17, 2026

Web & Domain Identity

Official Website icbiothera.com
Domain Registered Date Jul 1, 2024

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Seed announced

  2. Milestone

    Website domain registered

    icbiothera.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Immuno Cancer Biotherapeutics.

Funding History

1 Round
Seed equity · Oct 15, 2026
Undisclosed

Founders & Leadership

1

James Robl

Co-founder, President and CSO

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts